NLRP3 and metabolic dysfunction-associated steatohepatitis: During the development of NASH, activation of NLRP3 inflammasome mediates caspase-1 activation in bone marrow-derived KCs, which then release pro-inflammatory signals that can activate hepatic stellate cells (HSCs) responsible for collagen deposition and fibrosis in the liver [84].